The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Sign Up to like & getrecommendations! Published in 2017 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2017.04.007
Abstract: RATIONALE Anti-aminoacyl transfer RNA synthetase antibodies (anti-ARS) are a group of myositis-specific autoantibodies that are detected in the sera of patients with polymyositis and dermatomyositis (PM/DM) and also in those of patients with idiopathic interstitial… read more here.
Keywords: term outcome; long term; ild without; ars ild ... See more keywords